share_log

Clearmind Medicine (NASDAQ:CMND) Trading Down 1.7%

Defense World ·  Feb 1, 2023 02:02

Shares of Clearmind Medicine Inc. (NASDAQ:CMND – Get Rating) fell 1.7% during mid-day trading on Tuesday . The stock traded as low as $3.35 and last traded at $3.57. 126,904 shares were traded during mid-day trading, an increase of 31% from the average session volume of 97,127 shares. The stock had previously closed at $3.63.

Clearmind Medicine Stock Down 1.7 %

The business's 50-day moving average price is $3.82.

About Clearmind Medicine

(Get Rating)

Clearmind Medicine Inc, a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors.

See Also

  • Get a free copy of the StockNews.com research report on Clearmind Medicine (CMND)
  • Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
  • Dividend King Sysco: Buying On The Dip
  • Is the 1,600% Rise in Genius Group Stock Justified?
  • After Further Review, Investors Liked Exxon Mobil's Earnings
  • Will Caterpillar Dig Its Way To Another Buying Opportunity?

Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment